. Glutaminyl cyclase inhibition attenuates pyroglutamate Abeta and Alzheimer's disease-like pathology. Nat Med. 2008 Oct;14(10):1106-11. Epub 2008 Sep 28 PubMed.

Recommends

Please login to recommend the paper.

Comments

Make a Comment

To make a comment you must login or register.

Comments on Primary Papers and News

  1. This seems to be a very interesting and consistent hypothesis opening exciting avenues for drug development. Potentially a breakthrough. Has it been possible to reconcile the data with the reference below?

    View all comments by Karl Naegler